R1 RCM Inc. found using ticker (RCM) have now 10 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The target price ranges between 35 and 22 calculating the average target price we see 31.1. Now with the previous closing price of 25.63 this indicates there is a potential upside of 21.3%. The 50 day moving average now sits at 22.81 and the 200 day MA is 23.89. The company has a market cap of $7,211m. Find out more information at: https://www.r1rcm.com
The potential market cap would be $8,750m based on the market concensus.
R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company also provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. The company was founded in 2003 and is headquartered in Murray, Utah.
